A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

被引：3
|
作者：
Burke, Michael J. [1 ]
Lamba, Jatinder
Weigel, Brenda
Bachanova, Veronika
Verneris, Michael R. [2 ]
Miller, Jeffrey S. [3 ]
机构：
[1] Univ Minnesota, Div Hematol Oncol, Minneapolis, MN USA
[2] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4307.4307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4307
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Wetzler, Meir
    Thomas, Debora A.
    Wang, Eunice S.
    Shepard, Robert
    Ford, Laurie A.
    Heffner, Thompson L.
    Parekh, Samir
    Andreeff, Michael
    O'Brien, Susan
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 430 - 434
  • [22] PHARMACOKINETICS OF SELINEXOR IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A PHASE I TRIAL.
    Badawi, M.
    Walker, A.
    Mims, A.
    Vasu, S.
    Blum, W.
    Klisovic, R.
    Bhatnagar, B.
    Phelps, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S51 - S51
  • [23] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Jeha, S
    Gaynon, PS
    Razzouk, BI
    Franklin, J
    Kadota, R
    Shen, V
    Litchtman-Jones, L
    Rytting, M
    Bomgaars, LR
    Rheingold, S
    Ritchey, K
    Albano, E
    Arceci, RJ
    Goldman, S
    Griffin, T
    Altman, A
    Gordon, B
    Steinherz, L
    Weitman, S
    Steinherz, P
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1917 - 1923
  • [24] An Open-Label Phase II Trial of the Combination of Decitabine, SQ Bortezomib and Pegylated Liposomal Doxorubicin for the Treatment of Patients with Relapsed/Refractory Acute Myelogenous Leukemia
    Potter, Laura A.
    Galkin, Maria
    Rosenberg, Aaron S.
    Hoeg, Rasmus T.
    Abedi, Mehrdad
    Tuscano, Joseph M.
    Jonas, Brian A.
    BLOOD, 2021, 138
  • [25] Bortezomib Combined Chemotherapy for Children with Relapsed/refractory Acute Lymphoblastic Leukemia
    Sakaguchi, Hirotoshi
    Maemura, Ryo
    Yamamori, Ayako
    Wakamatsu, Manabu
    Yoshida, Nao
    Kato, Koji
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S89 - S90
  • [26] Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomibbased chemotherapy
    Zhao, Junmei
    Wang, Chao
    Song, Yongping
    Liu, Yuzhang
    Fang, Baijun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 211 - 214
  • [27] A Phase II Study of Combination Chemotherapy Including Bortezomib in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia: Investigator-Initiated Clinical Trial
    Miyagawa, Naoyuki
    Goto, Hiroaki
    Kikuta, Atsushi
    Kosaka, Yoshiyuki
    Sekimizu, Masahiro
    Nakayama, Hideki
    Yoshimura, Kenichi
    Iijima, Yuka
    Sanada, Masashi
    Ogawa, Chitose
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [28] Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis
    Baruchel, Andre
    Abrahamsson, Jonas
    Bertrand, Yves
    Gonzalez, Oscar
    Nysom, Karsten
    Quinones, Willy
    Rizzari, Carmelo
    Buechner, Jochen
    Cesaro, Simone
    Duarte, Joaquin
    Fagioli, Franca
    Kang, Hyoung Jin
    Kattamis, Antonis
    Leverger, Guy
    Ludwig, Kathleen
    Makiya, Monica L.
    Micalizzi, Concetta
    Nelken, Brigitte
    Tondel, Camilla
    Yoo, Keon Hee
    Ivanina, Inna
    Brillac, Claire
    Wang, Lynn
    Oprea, Corina
    Abbadessa, Giovanni
    Zwaan, C. Michel
    BLOOD, 2021, 138
  • [29] VM-26 AND CYTARABINE COMBINATION CHEMOTHERAPY IN REFRACTORY OR RELAPSED ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
    CARELLA, AM
    SANTINI, G
    MARTINENGO, M
    GIORDANO, D
    NATI, S
    CONGIU, A
    RISSO, M
    VIMERCATI, R
    CERRI, R
    ROSSI, E
    DAMASIO, E
    MARMONT, AM
    HAEMATOLOGICA, 1984, 69 (06) : 747 - 751
  • [30] Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael J.
    Ziegler, David S.
    Bautista, Francisco
    Attarbaschi, Andishe
    Gore, Lia
    Locatelli, Franco
    O'Brien, Maureen M.
    Pauly, Melinda
    Obreja, Mihaela
    Morris, Christopher L.
    Baruchel, Andre
    BLOOD, 2021, 138
12345